Αποτελέσματα Αναζήτησης
10 Φεβ 2021 · Some of the widely used strategies include manufacturer price controls in the form of cost plus pricing, internal and external reference pricing, manufacturer profit regulation, regulation of supply and distribution chain mark-ups, tax and tariff exemptions/relaxations, promotion of generic medicines, and application of health technology ...
2 ημέρες πριν · In the US, high prescription drug costs are a major barrier to the optimal treatment of many health conditions. About 3 in 10 adults struggle to afford their medicines, and rates are even higher among patients with multiple chronic conditions, those with low socioeconomic status, and those who identify as Black or Latino. 1,2 Notably, cost-related medication nonadherence is associated with ...
2 Σεπ 2011 · Efficient inventory management improves pharmaceutical product profitability by reducing procurement costs and preventing long-term storage, while poor inventory management hinders essential...
In naming drugs, the most important considerations are avoiding drug names that are too similar to existing names—and therefore might compromise patient safety—and making sure the drug name communicates accurate information about the action or use of the substance.
28 Σεπ 2020 · Unaffordable prices can be one of the biggest barriers to access to pharmaceutical products. A new WHO guideline for countries on managing pharmaceutical prices aims to help governments overcome this barrier and better address national public health needs.
Inventory management in a pharmacy has two main aims: • reducing purchasing and operating costs. • maintaining an optimal inventory to meet the needs of customers and the requirements of the doctor. From a financial point of view, effective inventory management improves gross and net profit by reducing operating costs.
Exerting pressure on the federal government to allow the importation of prescription drugs: The price of drugs in other developed nations are often dramatically lower than those paid by American consumers, likely due to the lack of centralized drug procurement and coverage decisions in the United States.
